Detection and Quantification of Anthrax Lethal Factor in Serum by Mass Spectrometry

Anne E. Boyer, Conrad P. Quinn, Adrian R. Woolfitt, James L. Pirkle, Lisa G. McWilliams,§ Karen L. Stamey, Dennis A. Bagarozzi, John C. Hart, Jr., and John R. Barr*
Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, 4770 Buford Highway, NE, Atlanta, Georgia 30341, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, 1600 Clifton Road, Atlanta, Georgia 30333, Battelle Memorial Institute under contract at the Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Atlanta, Georgia 30341, and Centers for Disease Control and Prevention, National Center for Preparedness, Detection, and Control of Infectious Diseases, Division of Scientific Resources, 1600 Clifton Road, Atlanta, Georgia 30333
Anal. Chem., 2007, 79 (22), pp 8463–8470
DOI: 10.1021/ac701741s
Publication Date (Web): October 12, 2007
Copyright Not subject to U.S. Copyright. Published 2007 American Chemical Society

 Centers for Disease Control and Prevention, National Center for Environmental Health.

,

 Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases.

,
§

 Battelle Memorial Institute.

,

 Centers for Disease Control and Prevention, National Center for Preparedness, Detection, and Control of Infectious Diseases.

,
*

 Corresponding author. E-mail:  JBarr@cdc.gov. Phone: 770-488-7848. Fax:  770-488-0509.

Abstract

The lethal toxin produced during Bacillus anthracis infection is a complex of protective antigen, which localizes the toxin to the cell receptor, and lethal factor (LF), a zinc-dependent endoproteinase whose known targets include five members of the mitogen-activated protein kinase kinase (MAPKK) family of response regulators. We have developed a method for detecting functional LF in serum. Anti-LF murine monoclonal antibodies immobilized on magnetic protein G beads were used to capture and concentrate the LF from serum. The captured LF was exposed to an optimized MAPKK-based peptide substrate, which it hydrolyzed into two smaller peptides. The LF cleavage products were then analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MS) and quantified by isotope dilution-MS. The entire analytical method can be performed in less than 4 h with detection of LF levels as low as 0.05 ng/mL. The method was used to quantify LF levels in serum from rhesus macaques infected with B. anthracis. Serum samples obtained at day 2 postinfection contained 30−250 ng/mL LF and illustrated the clear potential to detect LF earlier in the infection cycle. This method represents a highly specific and rapid diagnostic tool for early anthrax and has a potential additional role as a research tool for understanding toxemia and effects of medical countermeasures for anthrax.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

History

  • Published In Issue November 15, 2007
  • Received for review August 17, 2007. Accepted September 21, 2007.

Recommend & Share

Related Content

Other ACS content by these authors: